femoropopliteal

Giannopoulos Drug-Eluting Stent Figure 1

Original Contribution

Concomitant Drug-Coated Balloon Angioplasty With Bail-Out Use of Eluvia Drug-Eluting Stent: Is There Any Downside to a Double Dose of Paclitaxel?

06/01/2022

Stefanos Giannopoulos, MD¹; Eric A. Secemsky, MD²; Peter A. Schneider, MD³; Ehrin J. Armstrong, MD¹

Stefanos Giannopoulos, MD1; Eric A. ...

The application of 2 distinct and simultaneously applied drug-delivery platforms for the treatment of peripheral artery disease has not been studied. This study investigated the outcomes of femoropopliteal disease treated with drug-coated...

The application of 2 distinct...

06/01/2022

Journal of Invasive Cardiology

Endovascular Techniques

A Tactical Approach to Arterial Access for Critical Limb Ischemia

02/01/2019

Vinayak Subramanian¹; Rohan Pasi²; Eric M. Weekman³; George L. Adams, MD⁴

¹UNC School of Medicine, Chapel Hill, North Carolina; ²Enloe High School, Raleigh, North Carolina; ³North Carolina State University, Raleigh, North Carolina; ⁴UNC REX Healthcare, Raleigh, North Carolina.

Vinayak Subramanian1; Rohan Pasi2; Er...

As incidence of diabetes and chronic kidney disease has increased, peripheral arterial disease has emerged as a significant public health challenge worldwide.

As incidence of diabetes and...

02/01/2019

Vascular Disease Management

Review

Should We Routinely Stent the Femoropopliteal Artery? An Interventionalist`s Perspective

11/01/2015

Nicolas W. Shammas, MD, MS¹ and Subhash Banerjee, MD²

Nicolas W. Shammas, MD, MS1 and Subha...

An overview of the pros and cons of primary stenting of femoropopliteal (FP) arteries vs alternative approaches including provisional stenting following POBA, atherectomy and/or drug-coated balloons.

An overview of the pros and cons...

11/01/2015

Journal of Invasive Cardiology